Dr. Christopher Gordon. After completing his PhD at the University of Wollongong in 2007, which focused on the development of compounds that inhibit HIV, he commenced a postdoctoral fellowship at the University of Newcastle. In early 2010, he embarked on an international posting as a senior postdoctoral fellow at the University of Nottingham Centre for Biomolecular Sciences UK, where his research efforts focused on the development of next-generation antibiotics that function by inhibiting bacterial quorum sensing. In 2012, he returned to Australia as a university research fellow at the University of Newcastle, where he continued his research interests in developing next-generation antibiotics, anti-cancer agents and molecular probes to study post-translational protein modifications such as protein phosphorylation. He was awarded an ARC DECRA fellowship in 2013. Currently, Dr. Christopher is appointed as a senior lecturer of organic and medicinal sciences at Western Sydney University, Australia. His research focuses on utilizing flow chemistry methodologies to drive medicinal chemistry programs that are geared towards the development of antibacterial compounds, radiopharmaceuticals, cancer-suppressing agents, and molecular probes to study post-translation protein modifications.